1. Home
  2. Pharma & Healthcare
  3. Global Induced Pluripotent Stem Cells (iPSCs) Market Growth (Status and Outlook) 2020-2025

Global Induced Pluripotent Stem Cells (iPSCs) Market Growth (Status and Outlook) 2020-2025

Publication Month: Aug 2020 | No. of Pages: 118 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

According to this study, over the next five years the Induced Pluripotent Stem Cells (iPSCs) market will register a 12.7%% CAGR in terms of revenue, the global market size will reach $ 127.2 million by 2025, from $ 79 million in 2019. In particular, this report presents the global revenue market share of key companies in Induced Pluripotent Stem Cells (iPSCs) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Induced Pluripotent Stem Cells (iPSCs) market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Induced Pluripotent Stem Cells (iPSCs), covering the supply chain analysis, impact assessment to the Induced Pluripotent Stem Cells (iPSCs) market size growth rate in several scenarios, and the measures to be undertaken by Induced Pluripotent Stem Cells (iPSCs) companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Human iPSCs
Mouse iPSCs
Human iPSCs had a market share of 89.65% in 2019, followed by Mouse iPSCs.

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Academic Research is the largest segment of Induced Pluripotent Stem Cells (iPSCs) application,with a share of 32% in 2019.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Fujifilm Holding Corporation (CDI)
Ncardia
Astellas Pharma Inc
Fate Therapeutics, Inc
Sumitomo Dainippon Pharma
ReproCELL
Pluricell Biotech
Cell Inspire Biotechnology

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Induced Pluripotent Stem Cells (iPSCs) market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Induced Pluripotent Stem Cells (iPSCs) market by identifying its various subsegments.
Focuses on the key global Induced Pluripotent Stem Cells (iPSCs) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Induced Pluripotent Stem Cells (iPSCs) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Induced Pluripotent Stem Cells (iPSCs) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size 2015-2025
2.1.2 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region
2.2 Induced Pluripotent Stem Cells (iPSCs) Segment by Type
2.2.1 Human iPSCs
2.2.2 Human iPSCs
2.3 Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
2.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2015-2020)
2.3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (2015-2020)
2.4 Induced Pluripotent Stem Cells (iPSCs) Segment by Application
2.4.1 Academic Research
2.4.2 Drug Development and Discovery
2.4.3 Toxicity Screening
2.4.4 Regenerative Medicine
2.4.5 Others
2.5 Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
2.5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2015-2020)
2.5.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Application (2015-2020)

3 Global Induced Pluripotent Stem Cells (iPSCs) by Players
3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Players
3.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Players (2018-2020)
3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Players (2018-2020)
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Induced Pluripotent Stem Cells (iPSCs) by Regions
4.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions
4.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Growth
4.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Growth
4.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Growth
4.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth

5 Americas
5.1 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Countries
5.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
5.3 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions
6.2 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
6.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Induced Pluripotent Stem Cells (iPSCs) by Countries
7.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) by Countries
8.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
8.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast (2021-2025)
10.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Regions
10.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Type
10.8 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Application

11 Key Players Analysis
11.1 Fujifilm Holding Corporation (CDI)
11.1.1 Company Details
11.1.2 Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Fujifilm Holding Corporation (CDI) News
11.2 Ncardia
11.2.1 Company Details
11.2.2 Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Ncardia News
11.3 Astellas Pharma Inc
11.3.1 Company Details
11.3.2 Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.3.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Astellas Pharma Inc News
11.4 Fate Therapeutics, Inc
11.4.1 Company Details
11.4.2 Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.4.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Fate Therapeutics, Inc News
11.5 Sumitomo Dainippon Pharma
11.5.1 Company Details
11.5.2 Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.5.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Sumitomo Dainippon Pharma News
11.6 ReproCELL
11.6.1 Company Details
11.6.2 Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.6.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 ReproCELL News
11.7 Pluricell Biotech
11.7.1 Company Details
11.7.2 Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.7.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Pluricell Biotech News
11.8 Cell Inspire Biotechnology
11.8.1 Company Details
11.8.2 Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.8.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Cell Inspire Biotechnology News

12 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Human iPSCs
Table 5. Major Players of Mouse iPSCs
Table 6. Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2014-2019) ($ Millions)
Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2015-2020)
Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) ($ Millions)
Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2015-2020)
Table 10. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2018-2020) ($ Millions)
Table 11. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2018-2020)
Table 12. Global Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
Table 13. Induced Pluripotent Stem Cells (iPSCs) Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions 2015-2020
Table 18. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Countries (2015-2020)
Table 20. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) ($ Millions)
Table 21. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2015-2020)
Table 22. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) ($ Millions)
Table 23. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2015-2020)
Table 24. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions (2015-2020)
Table 26. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) ($ Millions)
Table 27. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2015-2020)
Table 28. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) ($ Millions)
Table 29. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2015-2020)
Table 30. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Countries (2015-2020)
Table 32. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) ($ Millions)
Table 33. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2015-2020)
Table 34. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) ($ Millions)
Table 35. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2015-2020)
Table 36. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) ($ Millions)
Table 39. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2015-2020)
Table 40. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) ($ Millions)
Table 41. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2015-2020)
Table 42. Key and Potential Regions of Induced Pluripotent Stem Cells (iPSCs)
Table 43. Key Application and Potential Industries of Induced Pluripotent Stem Cells (iPSCs)
Table 44. Key Challenges of Induced Pluripotent Stem Cells (iPSCs)
Table 45. Key Trends of Induced Pluripotent Stem Cells (iPSCs)
Table 46. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Regions
Table 48. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2021-2025) ($ Millions)
Table 49. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Type (2021-2025)
Table 50. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Application (2021-2025) ($ Millions)
Table 51. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Application (2021-2025)
Table 52. Fujifilm Holding Corporation (CDI) Details, Company Total Revenue (in $ million), Head Office, Induced Pluripotent Stem Cells (iPSCs) Major Market Areas and Its Competitors
Table 53. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 54. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2018-2020E)
Table 55. Fujifilm Holding Corporation (CDI) Main Business
Table 56. Fujifilm Holding Corporation (CDI) Latest Developments
Table 57. Ncardia Details, Company Total Revenue (in $ million), Head Office, Induced Pluripotent Stem Cells (iPSCs) Major Market Areas and Its Competitors
Table 58. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 59. Ncardia Main Business
Table 60. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2018-2020E)
Table 61. Ncardia Latest Developments
Table 62. Astellas Pharma Inc Details, Company Total Revenue (in $ million), Head Office, Induced Pluripotent Stem Cells (iPSCs) Major Market Areas and Its Competitors
Table 63. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 64. Astellas Pharma Inc Main Business
Table 65. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2018-2020E)
Table 66. Astellas Pharma Inc Latest Developments
Table 67. Fate Therapeutics, Inc Details, Company Total Revenue (in $ million), Head Office, Induced Pluripotent Stem Cells (iPSCs) Major Market Areas and Its Competitors
Table 68. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 69. Fate Therapeutics, Inc Main Business
Table 70. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2018-2020E)
Table 71. Fate Therapeutics, Inc Latest Developments
Table 72. Sumitomo Dainippon Pharma Details, Company Total Revenue (in $ million), Head Office, Induced Pluripotent Stem Cells (iPSCs) Major Market Areas and Its Competitors
Table 73. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 74. Sumitomo Dainippon Pharma Main Business
Table 75. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2018-2020E)
Table 76. Sumitomo Dainippon Pharma Latest Developments
Table 77. ReproCELL Details, Company Total Revenue (in $ million), Head Office, Induced Pluripotent Stem Cells (iPSCs) Major Market Areas and Its Competitors
Table 78. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 79. ReproCELL Main Business
Table 80. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2018-2020E)
Table 81. ReproCELL Latest Developments
Table 82. Pluricell Biotech Details, Company Total Revenue (in $ million), Head Office, Induced Pluripotent Stem Cells (iPSCs) Major Market Areas and Its Competitors
Table 83. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 84. Pluricell Biotech Main Business
Table 85. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2018-2020E)
Table 86. Pluricell Biotech Latest Developments
Table 87. Cell Inspire Biotechnology Details, Company Total Revenue (in $ million), Head Office, Induced Pluripotent Stem Cells (iPSCs) Major Market Areas and Its Competitors
Table 88. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 89. Cell Inspire Biotechnology Main Business
Table 90. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2018-2020E)
Table 91. Cell Inspire Biotechnology Latest Developments
List of Figures
Figure 1. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2015-2020)
Figure 5. Global Human iPSCs Market Size Growth Rate
Figure 6. Global Mouse iPSCs Market Size Growth Rate
Figure 7. Induced Pluripotent Stem Cells (iPSCs) in Academic Research
Figure 8. Global Induced Pluripotent Stem Cells (iPSCs) Market: Academic Research (2015-2020) ($ Millions)
Figure 9. Induced Pluripotent Stem Cells (iPSCs) in Drug Development and Discovery
Figure 10. Global Induced Pluripotent Stem Cells (iPSCs) Market: Drug Development and Discovery (2015-2020) ($ Millions)
Figure 11. Induced Pluripotent Stem Cells (iPSCs) in Toxicity Screening
Figure 12. Global Induced Pluripotent Stem Cells (iPSCs) Market: Toxicity Screening (2015-2020) ($ Millions)
Figure 13. Global Toxicity Screening YoY Growth ($ Millions)
Figure 14. Induced Pluripotent Stem Cells (iPSCs) in Regenerative Medicine
Figure 15. Global Induced Pluripotent Stem Cells (iPSCs) Market: Regenerative Medicine (2015-2020) ($ Millions)
Figure 16. Global Regenerative Medicine YoY Growth ($ Millions)
Figure 17. Induced Pluripotent Stem Cells (iPSCs) in Others
Figure 18. Global Induced Pluripotent Stem Cells (iPSCs) Market: Others (2015-2020) ($ Millions)
Figure 19. Global Others YoY Growth ($ Millions)
Figure 20. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2019
Figure 21. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions 2015-2020
Figure 22. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2015-2020 ($ Millions)
Figure 23. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2015-2020 ($ Millions)
Figure 24. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2015-2020 ($ Millions)
Figure 25. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2015-2020 ($ Millions)
Figure 26. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Countries in 2019
Figure 27. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2019
Figure 28. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2019
Figure 29. United States Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 30. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 31. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 32. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions in 2019
Figure 33. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2019
Figure 34. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2019
Figure 35. China Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 36. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 37. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 38. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 39. India Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 40. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 41. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Countries in 2019
Figure 42. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2019
Figure 43. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2019
Figure 44. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 45. France Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 46. UK Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 47. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 48. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 49. Spain Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 50. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Countries in 2019
Figure 51. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2019
Figure 52. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2019
Figure 53. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 54. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 55. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 56. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 57. GCC Countries Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2015-2020 ($ Millions)
Figure 58. Global Induced Pluripotent Stem Cells (iPSCs) arket Size Forecast (2021-2025) ($ Millions)
Figure 59. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 60. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 61. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 62. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 63. United States Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 64. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 65. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 66. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 67. China Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 68. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 69. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 70. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 71. India Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 72. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 73. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 74. France Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 75. UK Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 76. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 77. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 78. Spain Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 79. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 80. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 81. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 82. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)
Figure 83. GCC Countries Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2025 ($ Millions)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets